导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 28.63% | 151/1050 |
| 近一周 | 1.12% | 169/1104 |
| 近一月 | -3.54% | 613/1103 |
| 近一季 | 42.34% | 5/1092 |
| 近半年 | 33.28% | 71/1070 |
| 近一年 | 12.31% | 340/1018 |
| 近两年 | 76.01% | 336/926 |
| 近三年 | 33.35% | 376/834 |
| 成立以来 | 94.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.10% 476/1070 |
7.51% 578/1101 |
- - |
- - |
| 2025 | 24.07% 598/1065 |
10.30% 146/1014 |
6.69% 205/1038 |
23.15% 508/1050 |
-14.38% 972/1065 |
| 2024 | -15.24% 864/1011 |
-12.24% 829/960 |
-7.95% 784/983 |
16.62% 156/991 |
-10.03% 898/1011 |
| 2023 | -15.42% 541/952 |
-1.09% 673/880 |
-11.79% 804/895 |
1.00% 58/915 |
-4.02% 410/952 |
| 2022 | -20.52% 344/867 |
-12.22% 153/773 |
7.44% 378/806 |
-20.43% 764/845 |
5.92% 168/867 |
| 2021 | -4.03% 404/740 |
3.40% 71/580 |
19.14% 170/659 |
-8.41% 461/704 |
-14.94% 681/740 |
| 2020 | 64.71% 168/554 |
5.93% 63/419 |
37.10% 47/466 |
8.28% 296/517 |
4.75% 442/554 |
| 2019 | 52.34% 135/410 |
33.19% 206/1149 |
0.75% 261/1231 |
9.72% 118/390 |
3.46% 368/410 |
| 2018 | -19.73% 71/349 |
- - |
- - |
- - |
-16.25% 921/1080 |
| 2017 | 14.62% 112/285 |
- - |
- - |
- - |
- - |
| 2016 | -12.10% 79/205 |
- - |
- - |
- - |
- - |
| 2015 | 52.63% 19/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8665 | 61.36% |
| 招商前沿医疗保健股票C | 0.8313 | 61.04% |
| 招商医药健康产业股票 | 2.7000 | 53.78% |
| 前海开源公共卫生股票A | 0.4844 | 46.12% |
| 广发医药精选股票A | 1.3562 | 44.63% |
| 嘉实医疗保健股票 | 2.6570 | 42.34% |
| 前海开源公共卫生股票C | 0.4741 | 42.24% |
| 广发医药精选股票C | 1.3346 | 40.86% |
| 交银医药创新股票A | 2.9498 | 37.46% |
| 交银医药创新股票C | 3.1324 | 37.26% |
| 嘉实医疗保健股票 VS. 东吴新产业精选股票A(580008) |